Effects of end stage renal disease and aluminium hydroxide on triazolam pharmacokinetics. 1985

P D Kroboth, and R B Smith, and M R Silver, and R Rault, and M I Sorkin, and J B Puschett, and R P Juhl

Triazolam 0.5 mg was administered to 11 dialysis patients and 11 age, weight and sex matched controls. Peak plasma concentrations (Cmax) were higher in control subjects, but there were no other differences between the groups. When dialysis patients took triazolam with 3600 mg aluminum hydroxide suspension, Cmax and AUC were increased into the range observed in control subjects. It appears that triazolam can be used at normal doses in patients with renal dysfunction, without regard to interaction with aluminum hydroxide gel, or to alterations in elimination.

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006863 Hydrogen-Ion Concentration The normality of a solution with respect to HYDROGEN ions; H+. It is related to acidity measurements in most cases by pH pH,Concentration, Hydrogen-Ion,Concentrations, Hydrogen-Ion,Hydrogen Ion Concentration,Hydrogen-Ion Concentrations
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000536 Aluminum Hydroxide A compound with many biomedical applications: as a gastric antacid, an antiperspirant, in dentifrices, as an emulsifier, as an adjuvant in bacterins and vaccines, in water purification, etc. Hydrated Alumina,Aldrox,Algeldrate,Alhydrogel,Alugel,Amphojel,Basalgel,Brasivil,Dialume,Nephrox,Pepsamer,Rocgel,Alumina, Hydrated,Hydroxide, Aluminum

Related Publications

P D Kroboth, and R B Smith, and M R Silver, and R Rault, and M I Sorkin, and J B Puschett, and R P Juhl
May 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
P D Kroboth, and R B Smith, and M R Silver, and R Rault, and M I Sorkin, and J B Puschett, and R P Juhl
January 1988, Clinical pharmacology and therapeutics,
P D Kroboth, and R B Smith, and M R Silver, and R Rault, and M I Sorkin, and J B Puschett, and R P Juhl
January 1993, Nephron,
P D Kroboth, and R B Smith, and M R Silver, and R Rault, and M I Sorkin, and J B Puschett, and R P Juhl
November 2010, Anesthesia and analgesia,
P D Kroboth, and R B Smith, and M R Silver, and R Rault, and M I Sorkin, and J B Puschett, and R P Juhl
July 2023, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
P D Kroboth, and R B Smith, and M R Silver, and R Rault, and M I Sorkin, and J B Puschett, and R P Juhl
March 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation,
P D Kroboth, and R B Smith, and M R Silver, and R Rault, and M I Sorkin, and J B Puschett, and R P Juhl
February 1980, Antimicrobial agents and chemotherapy,
P D Kroboth, and R B Smith, and M R Silver, and R Rault, and M I Sorkin, and J B Puschett, and R P Juhl
January 2002, The Journal of international medical research,
P D Kroboth, and R B Smith, and M R Silver, and R Rault, and M I Sorkin, and J B Puschett, and R P Juhl
February 2001, Pharmacotherapy,
P D Kroboth, and R B Smith, and M R Silver, and R Rault, and M I Sorkin, and J B Puschett, and R P Juhl
September 1999, International journal of clinical pharmacology and therapeutics,
Copied contents to your clipboard!